The clinical relevance of antibodies to ribosomal P—where are we now?

REFERENCES

• Pincus T, Schur PH, Rose JA et al: Measurement of serum DNA binding activity in systemic lupus erythematosus. N Engl J Med 281: 701–705, 1969.
   PubMed Web of Science ®Google Scholar
• Sontheimer RD, Maddison PJ, Reichlin M et al.: Serologic and HLA association in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus. Ann Intern Med 97: 664–671, 1982.
   PubMed Web of Science ®Google Scholar
• Scott JS, Maddison PJ, Taylor PV et al: Connective tissue disease, antibodies to ribonuclear proteins and congenital heart block. N Engl J Med 309: 209–212, 1983.
   PubMed Web of Science ®Google Scholar
• Sturgill BC, Carpenter RR: Antibody to ribosomes in systemic lupus erythematosus. Arthritis Rheum 8: 213–218, 1965.
   PubMedGoogle Scholar
• Elkon KB, Parnassa AP, Foster CL: Lupus autoantibodies target ribosomal P proteins. J Exp Med 162: 549–571, 1985.
   Google Scholar
• Francoeur AM, Peebles CL, Heckman KJ et al: Identification of ribosomal protein autoantigens. J Immunol 135: 2378–2384, 1985.
   PubMedGoogle Scholar
• Elkin K, Skelly S, Parnassa A et al: Identification and chemical synthesis of a ribosomal protein antigenic determinant in systemic lupus erythematosus. Proc Natl Acad Sci USA 83: 7419–7423, 1986.
   Google Scholar
• Elkin KB, Bonfa E, Brot N: Antiribosomal antibodies in systemic lupus erythematosus. Rheum Dis Clin North Am 18: 377–390, 1992.
   Google Scholar
• Bonfa E, Elkin KB: Clinical and serological associations of the antiribosomal P protein antibody. Arthritis Rheum 29: 981–985, 1986.
   PubMed Web of Science ®Google Scholar
• Schneebaum AB, Singleton JD, Sterling GW et al: Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus. Am J Med 90: 54–62, 1991.
   PubMed Web of Science ®Google Scholar
• Teh LS, Bedwell AE, Isenberg DA et al: Antibodies to protein P in systemic lupus erythematosus. Ann Rheum Dis 51: 489–494, 1992.
   PubMedGoogle Scholar
• Fujimoto M, Sato S, Takehara K et al: Detection of antiribosomal P protein antibodies in patients with systemic sclerosis. Br J Rheumatol 34: 908–911, 1995.
   Google Scholar
• Sato T, Uchiumi T, Ozawa T et al: Autoantibodies against ribosomal proteins found with high frequency in patients with systemic lupus erythematosus with active disease./Rheumatol 18: 1681–1684, 1991.
   Google Scholar
• Nojima Y, Minota S, Yamada A et al: Correlation of antibodies to ribosomal P protein with psychosis in patients with systemic lupus erythematosus. Ann Rheum Dis 51: 1053–1055, 1992.
   PubMed Web of Science ®Google Scholar
• Yoshio T, Masuyama J, Ikeda M et al: Quantification of antiribosomal P0 protein antibodies by ELISA with recombinant P0 fusion protein and their association with central nervous system disease in systemic lupus erythematosus. J Rheumatol 22: 1681–1687, 1995.
   PubMed Web of Science ®Google Scholar
• Teh LS, Lee MK, Wang F et al: Antiribosomal P protein antibodies in different populations of patients with systemic lupus erythematosus. Br J Rheumatol 32: 663–665, 1993.
   PubMedGoogle Scholar
• Stafford HA, Anderson CA, Reichlin M: Unmasking of antiribosomal P autoantibodies in healthy individuals. J Immunol 155: 2754–2761, 1995.
   Google Scholar
• Teh LS, Isenberg DA: Antiribosomal P protein antibodies in systemic lupus erythematosus. A reappraisal. Arthritis Rheum 37: 307–315, 1994.
   PubMedGoogle Scholar
• Gibson T, Myers AR: Nervous system involvement in systemic lupus erythematosus. Ann Rheum Dis 35: 398–406, 1976.
   Web of Science ®Google Scholar
• Bonfa E, Golombek SJ, Kaufman LD et al: Association between lupus psychosis and antiribosomal P protein antibodies. N Engl J Med 317: 265–271, 1987.
   PubMed Web of Science ®Google Scholar
• Derksen RHWM, van Dam AP, Gmelig Meyling FHJ et al: A prospective study on antiribosomal P proteins in two cases of familial lupus and recurrent psychosis. Ann Rheum Dis 49: 779–782, 1990.
   PubMedGoogle Scholar
• Van Dam A, Nossent H, de Jong J et al: Diagnostic value of antibodies against ribosomal phospho-proteins: a cross sectional and longitudinal study. J Rheumatol 18: 1026–1034, 1991.
   PubMedGoogle Scholar
• Press J, Palayew K, Laxer RM et al: Antiribosomal P antibodies in pediatric patients with systemic lupus erythematosus and psychosis. Arthritis Rheum 39: 671–676, 1996Watanabe T, Sato T, Uchiumi T et al.: Neuropsychiatric manifestations in patients with systemic lupus erythematosus: diagnostic and predictive value of longitudinal examination of antiribosomal P antibody. Lupus 5: 178–183, 1996.
   Google Scholar
• Petri M: Antiribosomal P antibodies in SLE. A prospective cohort study (abstract). Arthritis Rheum 39 (suppl): S292, 1996.
   Google Scholar
• Jayne DRW, Jones SJ, Severn A et al: Severe pulmonary haemorrhage and systemic vasculitis in association with circulating anti-neutrophil cytoplasmic antibodies of IgM class only. Clin Nephrol 32: 101–106, 1989.
   PubMed Web of Science ®Google Scholar
• Amett FC, Hamilton RG, Roebber MG et al.: Increased frequencies of Sm and nRNP autoantibodies in American Blacks compared to Whites with systemic lupus erythematosus. J Rheumatol 15: 1773–1776, 1988.
   Google Scholar
• Amett FC: Genetic aspects of human lupus. Clin Immunol Immunopathol 63: 4–6, 1992.
   Google Scholar
• Teh LS, Doherty DG, Williams BD: HLA-DRB genes and antiribosomal antibodies in systemic lupus erythematosus. Br J Rheumatol 33: 1125–1126, 1994.
   PubMedGoogle Scholar
• Crow MK, DelGiudice-Asch G, Zehetbauer JB et al.: Autoantigen-specific T cell proliferation induced by the ribosomal P2 protein in patients with systemic lupus erythematosus. J Clin Invest 94: 345–352, 1994.
   PubMed Web of Science ®Google Scholar
• Koren E, Reichlin MW, Koscec M et al.: Autoantibodies to the ribosomal P proteins react with a plasma membrane related target on human cells. J Clin Invest 89: 1236–1241, 1992.
   PubMedGoogle Scholar
• Amos N, Teh LS, Gower DE et al.: Surface expression of epitope(s) recognised by antiribosomal P protein antibodies on neuroblastoma cells (abstract). Arthritis Rheum 35 (suppl 9): S159, 1992.
   Google Scholar
• Stacey DW, Skelly S, Watson T et al.: The inhibition of protein synthesis by IgG containing antiribosomal P autoantibodies from systemic lupus erythematosus proteins. Arch Biochem Biophys 267: 398–403, 1988.
   PubMedGoogle Scholar
• Gaburo N, Jr, Timo-Iaria C, Bueno C et al.: In vivo effects of antiribosomal P protein antibody injections into the lateral ventricle of the rat brain (abstract). Arthritis Rheum 38: S297, 1995.
   Google Scholar
• Iverson GL: Are antibodies to ribosomal P proteins a useful predictor of neuropsychiatric manifestations in patients with systemic lupus erythematosus. Lupus 5: 634–635, 1996.
   Google Scholar
• Rothfield NF: Systemic lupus erythematosus: clinical and laboratory aspects. In Arthritis and allied conditions (McCarty DJ, Ed.), pp. 691–714. Lea and Febiger, Philadelphia, 1993.
   Google Scholar
• Runyon BA, LaBrecque DR, Anuras S: The spectrum of liver disease in systemic lupus erythematosus. Am J Med 69: 187–194, 1980.
   PubMed Web of Science ®Google Scholar
• Gibson T, Meyers AR: Subclinical liver disease in systemic lupus erythematosus. J Rheumatol 8: 752–759, 1981.
   PubMed Web of Science ®Google Scholar
• Arnett FC, Reichlin M: Lupus hepatitis: An under recognised disease feature associated with autoantibodies to ribosomal P. Am J Med 99: 465–472, 1995.
   PubMed Web of Science ®Google Scholar
• Fox RA, Reichlin MW, Reichlin M, Isenberg DA: Liver Function test (LFT) abnormalities in systemic lupus erythematosus (SLE) (abstract). Br J Rheumatol (suppl 1) 36: 16, 1997.
   Google Scholar
• Matsumoto T, Yoshimine T, Shimouchi KI et al.: The liver in systemic lupus erythematosus: pathological analysis of 52 cases and review of Japanese autopsy registry data. Human Pathol 23: 1151–1158, 1992.
   PubMed Web of Science ®Google Scholar
• Koren E, Schnitz W, Reichlin M: Concomitant development of chronic active hepatitis and antibodies to ribosomal P proteins in a patient with systemic lupus erythematosus. Arthritis Rheum 36: 1325–1328, 1993.
   Google Scholar
• Hulsey M, Goldstein R, Scully L et al.: Anti-ribosomal P antibodies in systemic lupus erythematosus: a case-control study correlating hepatic and renal disease. Clin Immunol Immunopathol 74: 252–256, 1995.
   Google Scholar
• Koren E, Koscec M, Reichlin M et al.: Possible role of autoantibodies to ribosomal P protein in development of liver disease in patients with systemic lupus erythematosus (abstract). Arthritis Rheum 36: S72, 1993.
   Google Scholar
• Koffler D, Miller TE, Lahita RG: Studies on the specificity and clinical correlation of antiribosomal antibodies in systemic lupus erythematosus. Arthritis Rheum 22: 463–470, 1979.
   PubMed Web of Science ®Google Scholar
• Meroni PL, de Bartolo G, Barcellini W et al. : Antiribosomal ribonucleoprotein autoantibodies in systemic lupus erythematosus. Clin Immunol 4: 45–54, 1984.
   Google Scholar
• Okamura M, Kanayam Y, Amastu K et al.: Significance of enzyme linked immunosorbent assay (ELISA) for antibodies to double-stranded and single-stranded DNA in patients with lupus nephritis: correlation with severity of renal histology. Ann Rheum Dis 52: 14–20, 1993.
   PubMed Web of Science ®Google Scholar
• Martin AL, Reichlin M: Fluctuations of antibodies to ribosomal P proteins correlate with appearance and remission of nephritis in SLE. Lupus 5: 22–29, 1996.
   Web of Science ®Google Scholar